1302
Cediranib ( RECENTIN ; AZD2171 ) is an inhibitor of VEGF signaling that has been shown in experimental models to prevent VEGF - A - induced angiogenesis and primary tumor growth , yet the effects of cediranib on VEGF receptor ( VEGFR ) - 3 - mediated endothelial cell function and lymphangiogenesis are unknown .
 Anatomy: primary tumor; Anatomy: endothelial cell
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Anatomy 
Text: {0} 
Answer:
 Anatomy: primary tumor; Anatomy: endothelial cell